BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.200
-0.100 (-7.69%)
Apr 3, 2026, 1:44 PM IDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 31.33 million as of April 2, 2026. Its market cap has decreased by -33.18% in one year.
Market Cap
31.33M
Enterprise Value
13.55M
Revenue
3.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.20
Market Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 31.33M, an increase of 19,117.77%. That is a compound annual growth rate of 31.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 31.33M | -25.00% |
| Dec 31, 2025 | 41.77M | -51.17% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 428.71M |
| Geffen Residence & Renewal | 268.22M |
| Matricelf | 98.70M |
| Clal Biotechnology Industries | 48.47M |
| Evogene | 24.72M |
| Can-Fite BioPharma | 20.57M |
| XTL Biopharmaceuticals | 19.87M |
| BioLight Life Sciences | 19.71M |